Neal D. Shore, MD, FACS of Carolina Urologic Research Center explains how emerging data on resistance has changed treatment for advanced prostate cancer at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Advertisement
Advertisement